Key result
VNS reduces acute LPS-induced colonic inflammation via vagal efferents but recent colitis transiently abolishes protection.
Why the study?
The neuroimmune circuitry modulating colonic inflammation by vagus nerve stimulation remains underexplored, particularly regarding the influence of inflammatory history.
Does left cervical vagus nerve stimulation reduce acute LPS-induced inflammation in mouse models?
Does left cervical vagus nerve stimulation reduce acute LPS-induced inflammation in mouse models?
Vagus nerve stimulation reduces colonic inflammation via efferent pathways independent of canonical systemic anti-inflammatory pathways, but its efficacy is transiently abolished by recent local inflammatory history.
Answers are grounded in this paper and cite their sources.
VNS effects on acute colitis may be blunted by recent inflammation; hypothesis-generating for neuromodulation but leaves clinical translation open.
Bidirectional communication between the nervous and immune systems has been demonstrated to limit or enhance immune cell function across organ systems and conditions. Although these neuroimmune circuits can become activated as an anti-inflammatory reflex, vagus nerve stimulation (VNS) reduces inflammation in models of endotoxemia, rheumatoid arthritis, and intestinal inflammation. In the spleen during endotoxemia, VNS activates a “cholinergic anti-inflammatory pathway” (CAIP), whereby choline acetyltransferase (ChAT)-expressing T cells release acetylcholine to reduce macrophage activation. VNS can also drive CAIP-independent pathways to reduce inflammation in the spleen and intestinal tract, although the circuitry modulating colonic inflammation remains underexplored. Here, we demonstrate that left cervical VNS reduces acute LPS-induced inflammation, evidenced by reduced Tnfa expression in colon and spleen and decreased circulating TNFα. In the colon, these protective effects required efferent but not afferent VNS and were independent of ChAT+ T cells, IL10, β-adrenergic signaling, and colonic sympathetic innervation. Critically, the ability of VNS to modulate colonic inflammation depended on prior tissue-specific inflammation. Mice recovering from DSS colitis, despite near-complete histological recovery, were refractory to the protective effects of VNS in the colon. This lack of efficacy in the colon was not reflected in measures of inflammation in the spleen or serum, highlighting the need for target-organ-specific monitoring. This loss of efficacy after colonic inflammation was transient, with restoration occurring upon complete recovery. These findings demonstrate that VNS efficacy in colonic inflammation depends on circuitry distinct from canonical systemic anti-inflammatory pathways, and that tissue responsiveness is shaped by anatomical site and inflammatory history. Key Points Electrical stimulation of the left cervical vagus nerve reduces LPS-induced inflammation in the mouse colon. This colonic anti-inflammatory effect requires vagal efferents but not afferent signaling. Unlike canonical splenic anti-inflammatory pathways, the colonic response does not require ChAT+ T cells, IL-10, β-adrenergic signaling, or local sympathetic innervation. Recent DSS colitis abolishes colonic responsiveness to VNS despite preserved splenic and systemic anti-inflammatory effects. Recovery of VNS anti-inflammatory efficacy after colitis shows that neuroimmune responsiveness in the colon is dynamically shaped by inflammatory history.
No takes yet. Share an insight, caveat, or question.
Sanchez et al. (2026) studied Colonic inflammation. Left cervical vagus nerve stimulation (VNS) was evaluated on LPS-induced inflammation (Tnfa expression in colon and spleen, circulating TNFα). Left cervical vagus nerve stimulation reduces acute LPS-induced colonic inflammation via vagal efferents, but this protective effect is transiently abolished by recent DSS colitis.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: